Overview
- 77 inspections across 71 sites are on record.
- 371 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-12-23.
At a glance
Inspections
77
Sites
71
Observations
371
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Amneal Pharmaceuticals Private Limited | 23 Dec 2022 | Human Drugs | On file |
| Lupin Limited | 23 Nov 2022 | Human Drugs | On file |
| Maiva Pharma Private Limited | 29 Oct 2022 | Human Drugs | On file |
| Mylan Laboratories Limited | 23 Sep 2022 | Human Drugs | On file |
| Element Materials Technology Oakland-Concord | 22 Mar 2022 | Human Drugs | On file |
Sites inspected
Amneal Pharmaceuticals Private LimitedAhmedabad, India1 insp.
Lupin LimitedMandideep, India1 insp.
Maiva Pharma Private LimitedHosur, India1 insp.
Mylan Laboratories LimitedHosur, India1 insp.
Element Materials Technology Oakland-ConcordConcord, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Robert D Tollefsen5 shared
Dipesh K Shah4 shared
Tamil Arasu3 shared
Massoud Motamed3 shared
Joel D Hustedt3 shared
Peter T Erlandson3 shared
Lourdes Andujar3 shared
Debra M Emerson3 shared
Michael P Sheehan3 shared
Rajiv R Srivastava2 shared
Full investigator report
Get the verbatim findings behind Thomas J Arista's 371 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site